Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples